This section contains press releases and other materials from third parties (including paid content). JOBFlocks has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

Tipranks - Tipranks - Sat Aug 8, 1:44PM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS) and Celldex (CLDX).

Claim 55% Off TipRanks

Zoetis (ZTS)

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Zoetis, with a price target of $85.00. The company’s shares closed last Friday at $72.39.

According to TipRanks.com, Block is a 4-star analyst with an average return of 5.4% and a 49.6% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Elanco Animal Health, and Senseonics Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zoetis with a $97.00 average price target, representing a 24.5% upside. In a report released yesterday, William Blair also downgraded the stock to Hold.

See Insiders’ Hot Stocks on TipRanks >>

Celldex (CLDX)

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Celldex, with a price target of $61.00. The company’s shares closed last Friday at $41.70.

According to TipRanks.com, Kluska is a 5-star analyst with an average return of 23.3% and a 48.1% success rate. Kluska covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Mereo Biopharma Group Plc, and Ultragenyx Pharmaceutical. ;'>

Currently, the analyst consensus on Celldex is a Strong Buy with an average price target of $58.08, a 38.7% upside from current levels. In a report issued on July 22, Leerink Partners also maintained a Buy rating on the stock with a $70.00 price target.

Read More on ZTS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Market data provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.